Zhang, A., Li, X., Liu, H., & Zhang, F. (2025). Real‐World Efficacy and Safety of Dupilumab Retreatment in Adults With Relapsed Atopic Dermatitis: A Retrospective Study From China. Clinical & Experimental Allergy, 55(11), 1153. https://doi.org/10.1111/cea.70093
Chicago Style (17th ed.) CitationZhang, Anda, Xu Li, Hong Liu, and Furen Zhang. "Real‐World Efficacy and Safety of Dupilumab Retreatment in Adults With Relapsed Atopic Dermatitis: A Retrospective Study From China." Clinical & Experimental Allergy 55, no. 11 (2025): 1153. https://doi.org/10.1111/cea.70093.
MLA (9th ed.) CitationZhang, Anda, et al. "Real‐World Efficacy and Safety of Dupilumab Retreatment in Adults With Relapsed Atopic Dermatitis: A Retrospective Study From China." Clinical & Experimental Allergy, vol. 55, no. 11, 2025, p. 1153, https://doi.org/10.1111/cea.70093.